Germline-reverted Stem Antibody Expression
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization :
Other organizations : National Institutes of Health, National Institute of Allergy and Infectious Diseases, Ragon Institute of MGH, MIT and Harvard, Sanofi (United States), AVEO Oncology (United States)
Protocol cited in 1 other protocol
Variable analysis
- Germline-reverted variants of stem antibodies or VRC-01
- Binding to HA using PE-conjugated HAdSA probes derived from A/New Caledonia/20/1999
- Immunoglobulin surface expression confirmed by staining transfected cells with anti-huIgM Cy5.5PerCP
- Ability of IGHV1-69 alleles to differentially bind the anti-idiotypic monoclonal antibody G6 confirmed by co-staining transfected cells with G6-Alexa Fluor 488
- Expression of receptor IgM on the surface of Expi293 cells as previously described (17 (link))
- None specified
- None specified
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!